Gastroenterology Doctors in Great Falls, MT Accepting Medicare

4 Gastroenterology doctors found. Showing 1 - 4

Dr. Steven Jay Ayres, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888

Dr. Craig M Brayko, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 401 15th Ave S, #201, Great Falls, MT 59405 Phone: 406-727-2121    Fax: 406-727-2147

Gerald D Spencer, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1300 28th St S, Suite 3, Great Falls, MT 59405 Phone: 406-455-5870    Fax: 406-731-8079

Thomas J Attaway, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-455-5000    Fax: 406-731-8318

News Archive

Why the Mediterranean diet appers to protect against breast cancer

U.S. researchers have uncovered reasons why the Mediterranean diet, with its high intake of oleic acid-rich olive oil, seems to protect against breast cancer. They have also found evidence that oleic acid may have a future role in treatment. The findings are reported (Monday 10 January) in Annals of Oncology.

New discovery on programmed cell death

Investigators at St. Jude Children's Research Hospital have discovered a dance of proteins that protects certain cells from undergoing apoptosis, also known as programmed cell death. Understanding the fine points of apoptosis is important to researchers seeking ways to control this process.

Brain does most of the work in seeing the difference between colours, rather than the eye

Colour contrast is detected much earlier in the brain than previously thought, a new study shows. Scientists at Durham University have confirmed that colour contrast is first detected by part of the brain called primary visual cortex, which is located at the very back of the head where visual information first enters the cortex of the brain.

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study (RIBBON 2) of Avastin® (bevacizumab) in women who had previously been treated with initial (first-line) chemotherapy for advanced HER2-negative breast cancer and needed additional (second-line) treatment.

Read more Medical News

› Verified 6 days ago